
ELAN Stock Forecast & Price Target
ELAN Analyst Ratings
Bulls say
Elanco Animal Health is well-positioned for long-term success due to its diversified product portfolio and recent acquisitions of other animal health companies, such as Janssen Animal Health and Novartis Animal Health. The company's seven potential blockbuster launches and strong customer demand for their products are key catalysts for sales growth and margin expansion. Additionally, the company's top position in the Pet Retail market and its resilient demand for protein in the Farm Animal segment make Elanco a strong player in the $40B+ global animal health market.
Bears say
Elanco Animal Health is facing several challenges that could affect its stock price in the future. These include intense competition with other animal health companies, potential failures in research and development efforts, and changing market demand for its products due to disruptive innovation and regulatory restrictions. There is also a risk of negative impact from weather conditions and issues with manufacturing. Even with acquisitions and product launches planned, unfavorable regulatory/pipeline updates and approval of competitor products could further dampen investor confidence and lead to slower sales growth. Additionally, there is a concern about declining market share for certain products, such as flea and worm chewables for dogs, and a decline in the growth rate of the companion animal market. All of these factors could hinder Elanco's ability to achieve its revenue and earnings targets in the future.
This aggregate rating is based on analysts' research of Elanco Animal Health Inc and is not a guaranteed prediction by Public.com or investment advice.
ELAN Analyst Forecast & Price Prediction
Start investing in ELAN
Order type
Buy in
Order amount
Est. shares
0 shares